Merck

Interest in Consumer Drug Buys Waning?

Sanofi to Buy Hemophilia Specialist Bioverativ

UK Watchdog Finds Concordia Guilty of Market Abuse

Pfizer Mulls Sale of Consumer Health Unit

Teva Sheds Assets Worth $2.48 Billion

Old Levothyrox to be Reintroduced in France

Merck KGaA May Sell Consumer Health

EU Approves Merck KGaA MS Tablets for Marketing

Merck KGaA Opens Applications Lab in Shanghai

Merck KGaA Refines Life Science Network

Germany’s Merck may See EC Fine over Sigma-Aldrich

Merck KGaA and iOnctura in new JV

US Merck Halts Trial Enrollment After Deaths

UK Watchdog Accuses Merck of Breaking Competition Law

Chemspec Europe 2017 in Munich bigger than ever

Chemspec Europe 2017 Show Preview now available

Germany’s Merck Sells Biosimilars to Fresenius

Chemspec Europe 2017: Register now for the International Exhibition for Fine and Speciality Chemicals

Merck and Avillion in Psoriasis Pact

US Court Reopens 5,000 Fosamax Lawsuits

FDA Accepts Merck-Pfizer Biologics Application

Merck Opens Excipients Plant in Spain

Merck KGaA Buys Food Safety Firm BioControl

Sanofi and MSD End Vaccines JV

Experts Statements: Jason Apter, Merck

The Winning Formula

Merck KGaA Expands Roche Reagents Pact

Merck and Idemitsu to Collaborate on OLEDs

Merck KGaA Invests €250 Million in China

Merck and Pfizer in Lung Pact With Debiopharm

Merck KGaA Expands Spanish Biotech Site

Merck KGaA Targets €4 Billion in New Product Sales

Merck to Market JenKem’s PEG products

Merck KGaA Opens Darmstadt OLED Plant

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.